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Introduction: Previous research has shown inconsistencies in the association of tree nut consumption with risk
factors for cardiovascular disease (CVD) and metabolic syndrome (MetS).
Objective: To determine the association of tree nut consumption with risk factors for CVD and for MetS in adults.
Methods: NHANES 2005–2010 data were used to examine the associations of tree nut consumption with health
risks in adults 19+ years (n = 14,386; 51 % males). Tree nuts were: almonds, Brazil nuts, cashews, filberts [hazelnuts],
macadamias, pecans, pine nuts, pistachios, and walnuts. Group definitions were non-consumers < ¼ ounce/day and
consumers of≥¼ ounce/day tree nuts using data from 24-h dietary recalls. Means and ANOVA (covariate adjusted)
were determined using appropriate sample weights. Using logistic regression, odds ratios of being overweight (OW)/
obese (OB) (body mass index [BMI] >25/<30 and ≥30, respectively) and having CVRF or MetS, were determined.
Results: Tree nut consumption was associated with lower BMI (p = 0.004), waist circumference (WC) (p = 0.008), systolic
blood pressure (BP) (p = 0.001), Homeostatic Model Assessment—Insulin Resistance (p = 0.043), and higher high density
lipoprotein-cholesterol (p = 0.022), compared with no consumption, and a lower likelihood of OB (−25 %), OW/OB
(−23 %), and elevated WC (−21 %).
Conclusions: Tree nut consumption was associated with better weight status and some CVRF and MetS components.
Keywords: Tree Nuts, NHANES, Adults, Metabolic Syndrome, Cardiovascular Risk FactorsIntroduction
Tree nuts have been part of the diet of humans since
paleolithic times [1]. The nutrients found in tree nuts,
including almonds, Brazil nuts, cashews, filberts [hazel-
nuts], macadamias, pecans, pine nuts, pistachios, and
walnuts vary by species, but in general, they provide en-
ergy, vegetable protein, heart-healthy oils, including
monounsaturated fatty acids (MUFA) and polyunsatur-
ated fatty acids (PUFA), dietary fiber, calcium, potassium,
folate, magnesium, selenium, and vitamin E. Tree nuts
are also low in sodium and have no cholesterol [2].
Coupled with this positive nutrient profile, tree nuts also* Correspondence: coneil1@lsu.edu
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creativecommons.org/publicdomain/zero/1.0/provide phenols, phytosterols, flavonoids, resveratrol,
and other bioactive compounds [2, 3], which when
coupled with vitamin E and selenium, serve as anti-
oxidants, which may reduce the risk of cardiovascular
risk factors (CVRF) [4–7] and cardiovascular disease
[8, 9].
Recently, tree nut consumption was shown to have a
significant inverse association with all-cause mortality
and with death due to heart disease [8, 10]. The study by
Bao et al., [8] showed that the frequency of tree nut con-
sumption was associated with decreased risk for heart
and cardiovascular disease, with the number of deaths
lowest in those consuming tree nuts five or more times
a week. That study failed to show a significant associ-
ation with frequency of tree nut consumption and death
due to stroke or type 2 diabetes.ticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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sumption of tree nuts has been associated with healthier
levels of CVRF, including total cholesterol [7, 11–13],
low-density lipoprotein cholesterol (LDL-C) [7, 11–15],
high-density lipoprotein cholesterol (HDL-C) [7, 14], tri-
glycerides [7], apolipoprotein A [13, 16], and apolipopro-
tein B [11]; markers of oxidative stress [17, 18] or
inflammatory markers [19]; endothelial dysfunction [7,
20, 21]; insulin resistance [22, 23]; hyperglycemia [15];
and hemoglobin A1c [15]. However, other studies have
shown no significant effects on total cholesterol [24, 25],
LDL-C [24, 25], HDL-C [24], triglycerides [24, 25], C-
reactive protein (CRP) [16, 24], fasting blood sugar [25],
insulin resistance [21], hemoglobinA1c [21], and serum
fructosamine [24].
Cross-sectional studies of adults that have examined
the association between tree nut consumption and
CVRF have also shown conflicting results. Tree nut con-
sumers have been shown to have lower values for or de-
creased risk of higher body mass index (BMI) [5],
obesity [4], elevated waist circumference (WC) [5], low
HDL-C [5, 6], CRP [6], lower systolic (SBP) or diastolic
blood pressure (DBP) [5, 6, 26], elevated fasting glucose
[5], hemoglobin A1c [6], insulin [6], and a lower preva-
lence of metabolic syndrome (MetS) [5]. These studies
all looked at multiple CVRF and findings were inconsist-
ent since they also showed that tree nut consumption
was not associated with decreased values or decreased
risk of higher weight [6], elevated WC [6], components
of dyslipidemia [4], hypertension [4], elevated fasting
glucose [4, 6], or MetS [4, 6].
Reasons for these conflicting results in feeding and
epidemiologic studies are not clear, but may include the
populations studied, the type and amount of tree nut
consumed, the length of the feeding trial, and, in the
epidemiologic studies the method of classifying con-
sumers into groups. Disparities among these studies in-
dicate the need for further studies. There have been no
recent studies using nationally representative data that
has looked specifically at tree nut consumption and
CVRF. The purpose of this study was to examine this
association, using current data from participants of the
National Health and Nutrition Examination Survey
(NHANES) 2005–2010.
Subjects and methods
Study population and analytic sample
Data from the NHANES 2005–2006, 2007–2008, and
2009–2010 datasets were used to evaluate tree nut or
tree nut butter (these components were considered to-
gether and are referred to as tree nuts below) consump-
tion in the US population. Data from adults 19+ years of
age (y) (N = 14,386) participating in the NHANES were
combined to increase sample size [27, 28]. Analysesincluded only individuals with complete and reliable
dietary recalls as determined using the National Center
for Health Statistics staff. Females who were pregnant or
lactating were excluded from the study. In compliance
with federal law, the NHANES use defined strict proto-
cols to ensure confidentiality and protect participants’
identity. As this study used secondary data, stripped of
individual identifiers, it did not require institutional
review [29].
Demographic information, including age, gender, race-
ethnicity, poverty index ratio (PIR), physical activity
levels, and smoking status, used for covariates in the
statistical analyses outlined below, was determined via
interview [30]. Alcohol was also used as a covariate and
was determined using the 24-h dietary recalls described
below.
Dietary analyses
Dietary intake was determined using two multiple pass
24-h dietary recalls [31, 32]. The first recall was in-
person in the Mobile Examination Center [33] and the
second was conducted 3–10 days later via telephone
[34]. The US Environmental Protection Agency Food
Commodity Intake Database (FCID) commodity codes
[35] were used to identify ingredients of survey foods
that included tree nuts: almonds, Brazil nuts, cashews,
filberts [hazelnuts], macadamias, pecans, pine nuts, pis-
tachios, and walnuts.
The gram amount of tree nuts consumed by NHANES
2005–2010 respondents was determined by applying the
FDIC tree nut composition data to the respondent’s 24-
h recall dietary interview data. Tree nut intakes were
aggregated over the entire day. Usual intake (UI) was de-
termined using the National Cancer Institute method
with survey day (one or two) and a weekend day flag
(Friday/Saturday/Sunday versus others) as covariates
[36]. Tree nut or all nut consumers were defined by a UI
of at least ¼ ounce (7.0875 grams) per day [5].
Anthropometric and physiologic measures
Height, weight, and WC were obtained according to
NHANES protocols [37]. Body Mass Index (BMI) was
calculated as body weight (kilogram) divided by height
(meters) squared [38]. Systolic blood pressure and DBP
were determined using the standard NHANES protocol
[39]. High density lipoprotein-cholesterol were deter-
mined on non-fasted individuals [40] while LDL-C [41],
triglycerides [41], blood glucose [42], and insulin [42]
were determined on only fasted subjects; thus, not all in-
dividuals may have values for all tests.
Overweight/obesity and high WC were determined
using the National Heart Lung and Blood Institute Clin-
ical Guidelines [38]. Overweight was defined as a BMI >25
and ≤29.9; obesity was defined as a BMI ≥ 30 kg/m2. High
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males. The Homeostatic Model of Assessment-Insulin
Resistance (HOMA-IR), used to evaluate insulin resist-
ance, was calculated as: fasting serum insulin/fasting
plasma glucose [43]. Metabolic syndrome (MetS) was
defined using the National Heart Lung and Blood Insti-
tute Adult Treatment Panel III criteria [44]: having 3 or
more of the following risk factors: abdominal obesity,
WC > 102 cm (males), >88 cm (females); hypertension,
SBP ≥130 mmHg or DBP ≥85 mmHg or taking anti-
hypertensive medications; HDL-cholesterol, <40 mg/dL
(males), <50 mg/dL (females); high triglycerides, ≥150 mg/
dL or taking anti-hyperlipidemic medications; high fast-
ing glucose, ≥110 mg/dL or taking insulin or other
hypoglycemic agents. An elevated LDL-C was defined
as ≥100 mg/dL.Statistical analyses
Sample-weighted data were used in all statistical ana-
lyses; and, all analyses were performed using SUDAAN
Release11.0 (Research Triangle Institute, Research Tri-
angle Park, NC) to adjust the variance for the complex
sample design. For the 6-years 2005–2010, a 6-year weight
variable was created by assigning 13 of the 2 year weight for
2005–2006, 2007–2008, and 2009–2010 [27, 28]. A 6-year
MEC-examined sample weight was used in analyses of in-
take, body measurements, blood pressure, and laboratory
data, except a 6-year fasted sample weight was used in
analyses of LDL-C, triglycerides, plasma glucose, insulin,
and MetS.
The sample-weighted percentages (and standard error
of the percentages) of the adults in tree nut consumers
were calculated using PROC DESCRIPT of SUDAAN.
Least-square means (and the standard errors of the
least-square means) were calculated using PROC RE-
GRESS of SUDAAN. The adjusted prevalence of a risk
factor was determined by calculating the least-square
mean of a dichotomous variable using PROC REGRESS,
and odds ratios were calculated using PROC LOGISTIC
of SUDAAN.
Covariates for least-square mean values and odds ra-
tios of weight/adiposity related variables were, gender,
age (years), race-ethnicity, poverty index ratio, physical
activity level, smoking status and alcohol intake. The
least-square mean values and odds ratios of BP, blood
lipids, fasting glucose, and insulin were adjusted for
BMI (kg/m2) as well. A p value of <0.05 was considered
significant.Results
Nut consumption
Tree nut consumers (n = 755; 50.2 % female; mean age
51.18 years ± 0.42 SE) constituted approximately 6.8 % ofthe population. Details of the demographics of this
population have been published previously [45]. Mean
UI of tree nut consumers was 44.3 ± 1.6 g/d; whereas,
per captia UI was 3.3 ± 0.1 g/d.
Weight/adiposity measures/blood pressure
Table 1 shows tree nut consumers had better weight/
adiposity parameters than non- consumers. BMI
(27.9 ± 0.3 v 28.7 ± 0.1 kg/m2; p = 0.004), and WC
(95.8 ± 0.7 v 98.1 ± 0.3 cm; p = 0.008) were all signifi-
cantly lower in tree nut consumers. Systolic blood
pressure was lower in tree nut consumers (119.5 ±
0.8 v 122.1 ± 0.2 mm Hg; p = 0.001).
Physiologic measures
Table 2 shows that tree nut consumers had higher HDL-
C levels (54.4 ± 0.6 v 52.9 ± 0.3 mg/dL; p = 0.022) and
lower HOMA-IR values (3.0 ± 0.1 v 3.3 ± 0.1; p = 0.043)
than non-consumers. Odds ratio analyses (Table 3)
showed that tree nut consumers had a 25 % lower likeli-
hood of obesity (OR = 0.75; 95 % confidence interval
[CI] 0.60-0.95), a 23 % lower likelihood of overweight or
obesity (0.77; 0.62-0.95), and a 21 % lower likelihood of
an elevated WC (0.79; 0.64-0.99) than non-consumers.
Discussion
This study showed that those consuming tree nuts had
better weight/adiposity measures and a lower risk of
obesity, overweight/obesity, and elevated WC than non-
consumers. Tree nut consumers also had lower SBP and
higher levels of HDL-C. The association of tree nut con-
sumption and weight and cardiovascular risk factors
using NHANES data has not been examined since the
1999–2004 data sets were published. An advantage to
using data sets published after 2001–2002 cycle is that
two 24-h dietary recalls are available from participants.
Thus, since UI can be calculated [36], concerns about
using a single dietary recall in data analysis should be
assuaged.
Always of interest is to compare secular trends in con-
sumption of healthful foods, like tree nuts. However, it is
difficult to compare the percentage of individuals con-
suming tree nuts and the amount consumed by individ-
uals in three previous NHANES studies [5, 6, 46], since
the earlier studies used a single 24 h dietary recall and
this study used UI. Further, this study used the FCID
commodity codes [35] to determine intake, as opposed
to the food codes found in Food and Nutrient Database
for Dietary Studies [47] which are often used [5, 6]. The
advantage is that the FDIC database provides estimates
of food consumption, in terms of ingredients or as the
food “as eaten.” In this study, approximately 6.8 % of the
study population consumed tree nuts; although this
seems low, the weighted number actually represented
Table 1 The association of consuming tree nuts with weight/adiposity and blood pressure measurements in adults participating in
the 2005–2010 National Health and Nutrition Examination Survey
Variable Number Tree Nut Consumers LS Mean ± SE Non-Consumers LS Mean ± SE p
Weight (kg)a 14,229 80.7 ± 0.9 82.2 ± 0.3 0.102
BMI (kg/m2)a 14,204 27.9 ± 0.3* 28.7 ± 0.1* 0.004
WC (cm)a 13,838 96.1 ± 0.7* 98.0 ± 0.3* 0.008
Systolic BP (mm Hg)b 13,918 119.5 ± 0.8* 122.1 ± 0.2* 0.001
Diastolic BP (mm Hg)b 13,851 71.8 ± 0.8 70.6 ± 0.3 0.221
Abbreviations: BMI = Body mass index, WC =Waist circumference, BP = Blood pressure
aCovariates: Gender, Ethnicity, Age, Poverty Index Ratio, Physical Activity Level (sedentary, moderate, active), Current Smoker Status, and Alcohol
bCovariates: Gender, Ethnicity, Age, Poverty Index Ratio, Physical Activity Level (sedentary, moderate, active), Current Smoker Status, Alcohol, and BMI
*Significantly Different
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ber. Those consuming tree nuts consumed an average of
44.3 g which is higher than the ½ ounce (~14 g) that is
considered an ounce equivalent of a protein food by
MyPlate and higher than the US Food and Drug Admin-
istration’s reference amount customarily consumed of
30 g for all types of nuts and mixtures except butters
[48]. It is similar to the 1½ ounces (42.5 g) recom-
mended in the qualified health claim for tree nuts and
heart disease [49].
In this study tree nut consumers had lower mean
weight, BMI, and WC than non-consumers. There was
also a lower risk of obesity/overweight, obesity, and ele-
vated WC. Although tree nuts are an energy dense food,
an inverse association between tree nut consumption
and weight parameters or weight gain has been shown
previously in cross-sectional studies [4, 5], prospective
long-term cohort studies [50, 51], and feeding studies
[52, 53]. A recent meta-analysis of controlled clinical tri-
als looking at nut consumption and weight has alsoTable 2 The association of consuming tree nuts with physiologic m
and Nutrition Examination Survey
Variable Number Tree Nut Consumers LS M
LDL-C (mg/dL)a 6480 115.5 ± 2.4
HDL-C (mg/dL)a 13,666 54.4 ± 0.6*
Triglycerides (mg/dL)b 6621 127.4 ± 6.5
Glucose (mg/dL)c 6662 102.1 ± 1.2
Insulin (uU/mL) 6581 11.3 ± 0.5
HOMA-IR 6568 3.0 ± 0.1*
CRP (mg/dL)d 13,709 0.4 ± 0.04
Abbreviations: BMI = body mass index, WC =waist circumference, BP = blood pressure
cholesterol, HOMA-IR = Homeostatic Model of Assessment - Insulin Resistance, CRP = C
Covariates: Gender, Ethnicity, Age, Poverty Index Ratio, Physical Activity Level (sede
aTo convert mg/dL to mmol/L divide by 38.67
bTo convert mg/dL to mmol/L divide by 38.67
cTo convert mg/dL to mmol/L multiply by 0.055
dTo convert mg/dL to mmol/L multiply by 9.524
*Significantly Differentshown that diets “enriched with nuts” did not increase
weight or measures of adiposity [54].
The biological plausibility for these findings has been
offered previously [54, 55]. Due to their high vegetable
protein, dietary fiber, MUFA, and PUFA content, tree
nuts are a satiating food and following consumption, ap-
petite and consequently intake may be suppressed at
subsequent eating occasions. Nuts must be chewed so
that the particles are small enough to be swallowed;
mastication may modify appetite. Further, the energy in
nuts may be inefficiently absorbed. Finally, Atwater fac-
tors, when applied to almonds [56] and pistachios [57]
resulted in a 32 % and 5 % overestimation, respectively,
of their measured energy content. Obesity also contrib-
utes to the major causes of morbidity and mortality in
the US; thus, any dietary changes that can lower the risk
of obesity should be encouraged.
This study and both earlier studies [5, 6] of NHANES
participants have shown lower SBP in tree nut consumers
than in non-consumers. With relatively high levels ofeasures in adults participating in the 2005–2010 National Health
ean ± SE Non-Tree Nut Consumers LS Mean ± SE p
115.8 ± 0.6 0.902
52.9 ± 0.3* 0.022
134.1 ± 1.9 0.344
104.3 ± 0.4 0.061
12.1 ± 0.2 0.125
3.3 ± 0.1* 0.043
0.4 ± 0.01 0.276
, LDL-C = low-density lipoprotein cholesterol, HDL-C = high-density lipoprotein
-reactive protein
ntary, moderate, active), Current Smoker Status, Alcohol, and BMI
Table 3 Risk of overweight and obesity and cardiovascular and
metabolic syndrome risk factors in adult consumers and Non-
consumers of tree nuts participating in the 2005–2010 National
Health and Nutrition Examination Survey
Variable OR LCL UCL
Overweighta,b 1.02 0.67 1.24
Obesea,b 0.75* 0.60 0.95
Overweight or obesea,b 0.77* 0.62 0.95
WC elevateda,c 0.79* 0.64 0.99
Elevated systolic BPd 0.91 0.71 1.17
Elevated diastolic BPd 1.03 0.80 1.33
LDL-C elevatedd,e 0.80 0.57 1.14
HDL-C reducedd,e 0.85* 0.67 1.07
Triglycerides elevatedd,e 0.81 0.58 1.13
Glucose elevatedd,e 0.81 0.59 1.11
Insulin elevated (>85th Pctl)d 0.82 0.54 1.26
Metabolic syndromea,f 0.74 0.52 1.05
Abbreviations: WC =Waist circumference, BP = Blood pressure, LDL-C = Low-
density lipoprotein cholesterol, HDL-C = High-density lipoprotein cholesterol
For Tree Nut Consumers, the reference group was no tree nut consumption
aCovariates: Gender, Ethnicity, Age, Socioeconomic Status (PIR 0–1.25, 1.25-3.4,
≥ 3.25), Physical Activity Level (sedentary, moderate, active), Current Smoker
Status, and Alcohol
bOveweight was defined as a BMI 25–29.9; obese was defined as a BMI ≥ 30;
overweight or obese was defined as a BMI ≥25
cElevated WC was defined as >102 cm (males), >88 cm (females)
dCovariates: Gender, Ethnicity, Age, Socioeconomic Status (PIR 0–1.25, 1.25-3.,
≥ 3.25), Physical Activity Level (sedentary, moderate, active), Current Smoker
Status, Alcohol, and BMI
eReduced HDL-cholesterol was defined as <40 mg/dL
(males), <50 mg/dL (females); high triglycerides, ≥150 mg/dL or taking anti-
hyperlipidemic medications; high fasting glucose, ≥110 mg/dL or taking insulin
or other hypoglycemic agents. Elevated LDL-C ≥100 mg/dL
fMetabolic syndrome was defined using the National Heart Lung and Blood
Institute Adult Treatment Panel III criteria; that is having 3 or more of the
following risk factors: abdominal obesity, WC > 102 cm (males), >88 cm
(females); hypertension, SBP ≥130 mmHg or DBP ≥85 mmHg or taking
anti-hypertensive medications; HDL-cholesterol, <40 mg/dL (males), <50 mg/
dL (females); high triglycerides, ≥150 mg/dL or taking anti-hyperlipidemic
medications; high fasting glucose, ≥110 mg/dL or taking insulin or other
hypoglycemic agents
*p < 0.05
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magnesium, and dietary fiber, coupled with low levels of
sodium [2], tree nuts would appear to be a food associated
with low blood pressure and they are encouraged in the
DASH diet [58]. However, studies have shown that the ef-
fect of tree nut consumption on blood pressure is incon-
sistent. The cross-sectional PREDIMED study did not
show an effect of tree nut consumption on hypertension
[4]. Data from prospective cohorts are limited. Partici-
pants in the Physicians’ Health Study I [59] reported a
lower incidence of hypertension in lean men only; how-
ever, in the SUN study there was not relationship between
nut consumption and incident hypertension [60]. A review
of 19 clinical trials looking at blood pressure and nut con-
sumption showed inconsistent results, with 13 studiesshowing no changes in blood pressure, one showing an in-
crease in blood pressure, and the remaining five studies
showing a reduction [61].
Consistent with other cross-sectional studies [5, 6], this
study showed higher HDL-C levels in tree nut consumers
than in non-consumers. Cross-sectional studies are hy-
pothesis generating; thus, these findings led, in part, to
clinical trials (hypothesis testing) that examined diets
containing nuts versus those not containing nuts.
These clinical trials have shown inconsistent results
with regard to HDL-C levels. For example, Tappsell,
et al., [62] showed an increase in HDL-C levels in indi-
viduals after 6 months of consuming a diet containing
walnuts as compared to those consuming a control
diet; whereas, Sabaté, et al., [63] showed that HDL-C
levels were lower in those consuming 20 % of energy
from walnuts, as compared with those consuming the
control diet. Both of these studies were conducted in
specific groups, the first in diabetics and the second in
men only. To help reconcile these findings, a recent
pooled analysis of primary data from 25 tree nut con-
sumption trials with a total of 583 participants failed
to show a significant difference in mean HDL-C levels
between tree nut consumers and non-consumers [64].
Reasons for the differences between the results of
cross-sectional studies, such as NHANES, and clinical
trials are not clear but may reflect the population used,
the length of the study, the amount of specific tree
nuts consumed, and the assignment to consumption
groups in cross-sectional studies. Overall, the relation-
ship between lipid levels and tree nut consumption has
been inconsistent, but overall, the association is posi-
tive [63]. This is likely due to the low saturated fatty
acids, high MUFA, PUFA, and phytochemical content
of most tree nuts.
Metabolic Syndrome is characterized by dyslipidemia,
hypertension, abdominal obesity, insulin resistance, and
hyperglycemia; it is a major risk factor for cardiovascular
disease and type 2 diabetes [65]. It has previously been
shown that tree nut consumers have a lower prevalence
of MetS [5], but a previous cross-sectional study that
looked only at out-of-hand tree nut and peanut con-
sumption [6] failed to show that nut consumption was
associated with a reduced risk of MetS. One reason may
be that that study failed to show a difference in several
of the risk factors for MetS, including elevated WC, tri-
glycerides, and fasting glucose. Since this study also
failed to show a reduced risk of MetS in tree nut con-
sumers, additional studies are warranted.
Differences among results from the cross-sectional,
cohort, and feeding studies seen in the CVRF examined
may be the result of different tree nuts used in individual
feeding studies, which may reflect the different nutrient
profile of individual nut species; how consumption was
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markers studied; the characteristics of the population
tested, including gender or whether participants were
healthy or had been diagnosed with obesity, MetS, hyperli-
pidemics, or diabetes; or the length of the study.
Strengths and limitations
The strengths of this study included a large, nationally
representative population and use of UI in the analyses.
The limitations of the study are that results from any
cross-sectional epidemiologic study cannot be used to
determine cause and effect. Also since these data are
based on self-reported intake, it must be considered
whether tree nuts are reported differently than other
foods. If self-reported intake of nuts is different from
other foods it may make it more likely that consumers
and non-consumers were misclassified.
Conclusions and implications
The prevalence of tree nut consumers was low; however,
consumption was associated with a better weight/adi-
posity and CVRF profile than seen in non-consumers.
Health professionals, especially registered dietitians and
other health educators should provide diet counseling
and nutrition education programs that increase aware-
ness of the health benefits of tree nut consumption. Tree
nuts should be consumed as part of an overall healthful
meal pattern. Because of the conflicting results produced
when studying the health benefits of tree nuts, future re-
search should include more longitudinal studies and
intervention trials examining these potential benefits.
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